Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javle

Showing results (101-110 of 343) with videos related to

Pageof 35
Sort By:
Biochimica Et Biophysica Acta|March 17, 2016
The inflammatory inception of gallbladder cancerJaime A Espinoza, Carolina Bizama, Patricia García, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Annals of Surgical Oncology|August 21, 2007
A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective studyRenuka V Iyer, John Gibbs, Boris Kuvshinoff, et al.
International Journal of Gastrointestinal Cancer|August 20, 2005
Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinomaThaer Khoury, Krishdeep Chadha, Milind Javle, et al.
The Journal of Supportive Oncology|October 20, 2007
Malignant gastroparesis: pathogenesis and management of an underrecognized disorderKavitha R Donthireddy, Sikander Ailawadhi, Eiad Nasser, et al.
ESMO Open|December 18, 2021
Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)M M Javle, D-Y Oh, M Ikeda, et al.
Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-099: Lenvatinib With Pembrolizumab in Advanced Biliary Tract CancerKabir Grewal, Shubham Pant, Ian Hu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2004
Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinomaNeal W Wilkinson, Jennifer D Black, Elena Roukhadze, et al.
British Journal of Cancer|March 6, 2015
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancerM Zuo, A Rashid, C Churi, et al.
Pageof 35

Showing results (101-110 of 343) with videos related to

Sort By:
Pageof 35
Biochimica Et Biophysica Acta|March 17, 2016
The inflammatory inception of gallbladder cancerJaime A Espinoza, Carolina Bizama, Patricia García, et al.
Molecular Cancer Therapeutics|April 15, 2018
Clinical Next-Generation Sequencing for Precision Oncology in Rare CancersRoman Groisberg, David S Hong, Jason Roszik, et al.
Annals of Surgical Oncology|August 21, 2007
A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective studyRenuka V Iyer, John Gibbs, Boris Kuvshinoff, et al.
International Journal of Gastrointestinal Cancer|August 20, 2005
Expression of intestinal trefoil factor (TFF-3) in hepatocellular carcinomaThaer Khoury, Krishdeep Chadha, Milind Javle, et al.
The Journal of Supportive Oncology|October 20, 2007
Malignant gastroparesis: pathogenesis and management of an underrecognized disorderKavitha R Donthireddy, Sikander Ailawadhi, Eiad Nasser, et al.
ESMO Open|December 18, 2021
Varlitinib plus capecitabine in second-line advanced biliary tract cancer: a randomized, phase II study (TreeTopp)M M Javle, D-Y Oh, M Ikeda, et al.
Anticancer Research|April 22, 2011
Evidence for the efficacy of Iniparib, a PARP-1 inhibitor, in BRCA2-associated pancreatic cancerDavid R Fogelman, Robert A Wolff, Scott Kopetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|March 28, 2025
CLO25-099: Lenvatinib With Pembrolizumab in Advanced Biliary Tract CancerKabir Grewal, Shubham Pant, Ian Hu, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|May 4, 2004
Epidermal growth factor receptor expression correlates with histologic grade in resected esophageal adenocarcinomaNeal W Wilkinson, Jennifer D Black, Elena Roukhadze, et al.
British Journal of Cancer|March 6, 2015
Novel therapeutic strategy targeting the Hedgehog signalling and mTOR pathways in biliary tract cancerM Zuo, A Rashid, C Churi, et al.
Pageof 35